(MNST) Monster Beverage - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US61174X1090
Stock: Energy Drinks, Teas, Juices, Coffee, Beer
Total Rating 65
Risk 81
Buy Signal -0.13
| Risk 5d forecast | |
|---|---|
| Volatility | 22.8% |
| Relative Tail Risk | -7.28% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.43 |
| Alpha | 32.15 |
| Character TTM | |
|---|---|
| Beta | 0.153 |
| Beta Downside | 0.309 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.04% |
| CAGR/Max DD | 0.58 |
EPS (Earnings per Share)
Revenue
Description: MNST Monster Beverage March 05, 2026
Monster Beverage Corporation (MNST) develops, markets, and distributes energy drinks and concentrates globally. The company operates in four segments: Monster Energy Drinks, Strategic Brands, Alcohol Brands, and Other.
MNST offers a diverse product portfolio including carbonated and non-carbonated energy drinks, ready-to-drink teas, juices, coffee drinks, and various sodas. The beverage industry is highly competitive, with established brands and new entrants vying for market share.
The company markets products under numerous brands such as Monster Energy, Reign Total Body Fuel, NOS, and Burn. It also sells craft beers, flavored malt beverages, and hard seltzers under brands like Jai Alai IPA and Wild Basin Hard Seltzers. This diversification into alcoholic beverages represents an expansion beyond its core energy drink business.
MNST distributes its products through a wide network including bottlers, distributors, grocery chains, convenience stores, and e-commerce platforms. Understanding the nuances of its distribution channels is crucial for evaluating its market penetration. Further research on ValueRay can provide deeper insights into MNSTs operational specifics.
Headlines to watch out for
- Energy drink sales growth drives revenue expansion
- International market penetration boosts sales volume
- Input costs for aluminum and sugar impact margins
- Regulatory scrutiny on energy drink ingredients poses risk
- Alcohol brand acquisitions diversify revenue streams
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 1.91b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.20 > 0.02 and ΔFCF/TA -1.33 > 1.0 |
| NWC/Revenue: 47.18% < 20% (prev 33.95%; Δ 13.23% < -1%) |
| CFO/TA 0.21 > 3% & CFO 2.10b > Net Income 1.91b |
| Net Debt (-2.09b) to EBITDA (2.57b): -0.81 < 3 |
| Current Ratio: 3.70 > 1.5 & < 3 |
| Outstanding Shares: last quarter (986.8m) vs 12m ago 0.60% < -2% |
| Gross Margin: 55.85% > 18% (prev 0.54%; Δ 5.53k% > 0.5%) |
| Asset Turnover: 93.68% > 50% (prev 97.07%; Δ -3.39% > 0%) |
| Interest Coverage Ratio: 372.4 > 6 (EBITDA TTM 2.57b / Interest Expense TTM 6.60m) |
Altman Z'' 10.00
| A: 0.39 (Total Current Assets 5.36b - Total Current Liabilities 1.45b) / Total Assets 9.99b |
| B: 0.94 (Retained Earnings 9.35b / Total Assets 9.99b) |
| C: 0.28 (EBIT TTM 2.46b / Avg Total Assets 8.85b) |
| D: 5.36 (Book Value of Equity 9.30b / Total Liabilities 1.73b) |
| Altman-Z'' Score: 13.12 = AAA |
Beneish M -2.89
| DSRI: 1.20 (Receivables 1.62b/1.22b, Revenue 8.29b/7.49b) |
| GMI: 0.97 (GM 55.85% / 54.04%) |
| AQI: 0.90 (AQ_t 0.36 / AQ_t-1 0.39) |
| SGI: 1.11 (Revenue 8.29b / 7.49b) |
| TATA: -0.02 (NI 1.91b - CFO 2.10b) / TA 9.99b) |
| Beneish M-Score: -2.89 (Cap -4..+1) = A |
What is the price of MNST shares?
As of March 13, 2026, the stock is trading at USD 77.52 with a total of 5,937,678 shares traded.
Over the past week, the price has changed by +0.38%, over one month by -5.15%, over three months by +4.08% and over the past year by +41.53%.
Over the past week, the price has changed by +0.38%, over one month by -5.15%, over three months by +4.08% and over the past year by +41.53%.
Is MNST a buy, sell or hold?
Monster Beverage has received a consensus analysts rating of 3.76.
Therefor, it is recommend to hold MNST.
- StrongBuy: 10
- Buy: 3
- Hold: 9
- Sell: 2
- StrongSell: 1
What are the forecasts/targets for the MNST price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 87.2 | 12.4% |
| Analysts Target Price | 87.2 | 12.4% |
MNST Fundamental Data Overview March 11, 2026
P/E Trailing = 39.5361
P/E Forward = 33.557
P/S = 9.0463
P/B = 8.9749
P/EG = 1.841
Revenue TTM = 8.29b USD
EBIT TTM = 2.46b USD
EBITDA TTM = 2.57b USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = -2.09b USD (from netDebt column, last quarter)
Enterprise Value = 72.27b USD (75.03b + (null Debt) - CCE 2.77b)
Interest Coverage Ratio = 372.4 (Ebit TTM 2.46b / Interest Expense TTM 6.60m)
EV/FCF = 36.76x (Enterprise Value 72.27b / FCF TTM 1.97b)
FCF Yield = 2.72% (FCF TTM 1.97b / Enterprise Value 72.27b)
FCF Margin = 23.70% (FCF TTM 1.97b / Revenue TTM 8.29b)
Net Margin = 22.97% (Net Income TTM 1.91b / Revenue TTM 8.29b)
Gross Margin = 55.85% ((Revenue TTM 8.29b - Cost of Revenue TTM 3.66b) / Revenue TTM)
Gross Margin QoQ = 55.53% (prev 55.73%)
Tobins Q-Ratio = 7.23 (Enterprise Value 72.27b / Total Assets 9.99b)
Interest Expense / Debt = unknown (Interest Expense 300k / Debt none)
Taxrate = 20.96% (119.1m / 568.3m)
NOPAT = 1.94b (EBIT 2.46b * (1 - 20.96%))
Current Ratio = 3.70 (Total Current Assets 5.36b / Total Current Liabilities 1.45b)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = -0.81 (Net Debt -2.09b / EBITDA 2.57b)
Debt / FCF = -1.06 (Net Debt -2.09b / FCF TTM 1.97b)
Total Stockholder Equity = 7.43b (last 4 quarters mean from totalStockholderEquity)
RoA = 21.52% (Net Income 1.91b / Total Assets 9.99b)
RoE = 25.65% (Net Income TTM 1.91b / Total Stockholder Equity 7.43b)
RoCE = 28.77% (EBIT 2.46b / Capital Employed (Total Assets 9.99b - Current Liab 1.45b))
RoIC = 25.98% (NOPAT 1.94b / Invested Capital 7.48b)
WACC = 6.48% (E(75.03b)/V(75.03b) * Re(6.48%) + (debt-free company))
Discount Rate = 6.48% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -3.17%
[DCF] Terminal Value 86.13% ; FCFF base≈1.83b ; Y1≈2.20b ; Y5≈3.55b
[DCF] Fair Price = 90.54 (EV 86.49b - Net Debt -2.09b = Equity 88.57b / Shares 978.3m; r=6.48% [WACC]; 5y FCF grow 21.81% → 2.90% )
EPS Correlation: -28.97 | EPS CAGR: -4.65% | SUE: -0.02 | # QB: 0
Revenue Correlation: 89.43 | Revenue CAGR: 9.46% | SUE: 1.27 | # QB: 2
EPS next Quarter (2026-06-30): EPS=0.58 | Chg7d=+0.003 | Chg30d=+0.004 | Revisions Net=+3 | Analysts=5
EPS current Year (2026-12-31): EPS=2.27 | Chg7d=+0.007 | Chg30d=+0.010 | Revisions Net=+1 | Growth EPS=+16.8% | Growth Revenue=+10.9%
EPS next Year (2027-12-31): EPS=2.57 | Chg7d=-0.008 | Chg30d=-0.005 | Revisions Net=+0 | Growth EPS=+13.4% | Growth Revenue=+8.4%
[Analyst] Revisions Ratio: +1.00 (3 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.4% (Discount Rate 7.9% - Earnings Yield 2.5%)
[Growth] Growth Spread = +4.9% (Analyst 10.3% - Implied 5.4%)
P/E Forward = 33.557
P/S = 9.0463
P/B = 8.9749
P/EG = 1.841
Revenue TTM = 8.29b USD
EBIT TTM = 2.46b USD
EBITDA TTM = 2.57b USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = -2.09b USD (from netDebt column, last quarter)
Enterprise Value = 72.27b USD (75.03b + (null Debt) - CCE 2.77b)
Interest Coverage Ratio = 372.4 (Ebit TTM 2.46b / Interest Expense TTM 6.60m)
EV/FCF = 36.76x (Enterprise Value 72.27b / FCF TTM 1.97b)
FCF Yield = 2.72% (FCF TTM 1.97b / Enterprise Value 72.27b)
FCF Margin = 23.70% (FCF TTM 1.97b / Revenue TTM 8.29b)
Net Margin = 22.97% (Net Income TTM 1.91b / Revenue TTM 8.29b)
Gross Margin = 55.85% ((Revenue TTM 8.29b - Cost of Revenue TTM 3.66b) / Revenue TTM)
Gross Margin QoQ = 55.53% (prev 55.73%)
Tobins Q-Ratio = 7.23 (Enterprise Value 72.27b / Total Assets 9.99b)
Interest Expense / Debt = unknown (Interest Expense 300k / Debt none)
Taxrate = 20.96% (119.1m / 568.3m)
NOPAT = 1.94b (EBIT 2.46b * (1 - 20.96%))
Current Ratio = 3.70 (Total Current Assets 5.36b / Total Current Liabilities 1.45b)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = -0.81 (Net Debt -2.09b / EBITDA 2.57b)
Debt / FCF = -1.06 (Net Debt -2.09b / FCF TTM 1.97b)
Total Stockholder Equity = 7.43b (last 4 quarters mean from totalStockholderEquity)
RoA = 21.52% (Net Income 1.91b / Total Assets 9.99b)
RoE = 25.65% (Net Income TTM 1.91b / Total Stockholder Equity 7.43b)
RoCE = 28.77% (EBIT 2.46b / Capital Employed (Total Assets 9.99b - Current Liab 1.45b))
RoIC = 25.98% (NOPAT 1.94b / Invested Capital 7.48b)
WACC = 6.48% (E(75.03b)/V(75.03b) * Re(6.48%) + (debt-free company))
Discount Rate = 6.48% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -3.17%
[DCF] Terminal Value 86.13% ; FCFF base≈1.83b ; Y1≈2.20b ; Y5≈3.55b
[DCF] Fair Price = 90.54 (EV 86.49b - Net Debt -2.09b = Equity 88.57b / Shares 978.3m; r=6.48% [WACC]; 5y FCF grow 21.81% → 2.90% )
EPS Correlation: -28.97 | EPS CAGR: -4.65% | SUE: -0.02 | # QB: 0
Revenue Correlation: 89.43 | Revenue CAGR: 9.46% | SUE: 1.27 | # QB: 2
EPS next Quarter (2026-06-30): EPS=0.58 | Chg7d=+0.003 | Chg30d=+0.004 | Revisions Net=+3 | Analysts=5
EPS current Year (2026-12-31): EPS=2.27 | Chg7d=+0.007 | Chg30d=+0.010 | Revisions Net=+1 | Growth EPS=+16.8% | Growth Revenue=+10.9%
EPS next Year (2027-12-31): EPS=2.57 | Chg7d=-0.008 | Chg30d=-0.005 | Revisions Net=+0 | Growth EPS=+13.4% | Growth Revenue=+8.4%
[Analyst] Revisions Ratio: +1.00 (3 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.4% (Discount Rate 7.9% - Earnings Yield 2.5%)
[Growth] Growth Spread = +4.9% (Analyst 10.3% - Implied 5.4%)